CSL-760

N/A

Report date: 2024/04/02 14:24:48

Base Information

Drug NameCSL-760
Drug Alias NameCOVID-19 Immunoglobulin-VF (Csl Behring)Anti-SARS-CoV-2 Hyperimmune Globulin (Csl Behring)TAK-888CSL-760CoVIg-19
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl Behring
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A